¡¶Ãâ·Ñ³ß´çÊ®´óÖ±²¥Æ½Ì¨,¸öÐÔ»¯Ñ§Ï°ÏµÍ³½á¹¹ÆÊÎö-ÇóÊÇ¡·¾çÇé¼ò½é£ºÔÚ½»Í¨·½ÃæÁõºé½¨ÒéÏ£Íûµ÷½âÐÞ·ʱ¶ÎÖ»¹ÜÓëÂÃÓÎÍú¼¾´í·åÐí¶àÓοͷ´Ó¦Ã¿Äê7Ôµ½11ÔÂʱ´úÊǸÊ×ÎÂÃÓÎÍú¼¾¿ÉÊǾ³£»áÓöµ½Ö÷ҪͨÐÐõè¾¶ÐÞ·µÄÇéÐν»Í¨Â·¿öÇ·ºÃ»áÓ°ÏìÓοͳöÐÐÒâÔ¸´Ó¶ø¶ÔÍâµØ×¡ÃñÊÕÈ뱬·¢Ó°ÏìÒò´ËËûºôÓõÏà¹Ø½»Í¨²¿·ÖÄÜе÷Ò»ÏÂÐÞ·µÄʱ¼ä¶ÎÔö½øÎÄ»¯ºÍÂÃÓÎÉú³¤ÔöÌíÍâµØ×¡ÃñÊÕÈëͬʱËûÒÔΪͨÍù¸Ê×εĹúµÀ317¡¢318¼°¸ßËÙ¹«Â·ÏÞËÙÌ«µÍÐí¶àµØ·½ÏÞËÙ40km/hÓ°ÏìÁËÓο͵ÄÌåÑé...É̶ӵÄÊ×ÁìÒ»Ñùƽ³£¶¼ÊÇÈýתÐÞΪÀàËÆ¼Ö¸»ÕâµÈËÄתµÄÍ·ÁìÕվɽÏÁ¿ÉÙ¼ûµÄÃâ·Ñ³ß´çÊ®´óÖ±²¥Æ½Ì¨,¸öÐÔ»¯Ñ§Ï°ÏµÍ³½á¹¹ÆÊÎö-ÇóÊÇÔªÁ«ÏÝÈëÉî˼ËûÕæÕýÉèÉí´¦µØµÄÕâÑùÏëÈ»ºóËûµÃ³öЧ¹ûÒÔÊ®Íò·ÖµÄÈÏÕæÉñÉ«´ðµÀ£ºÊǵÄÎÒ»áÕâô×öµÄƽ°²µØ½ÓÊÜéæÃü²»¹ÜÊÇÈκÎÈËÓÉÓÚÎÒÖªµÀÕâ¶¼ÊÇËÞÃüµÄ°²ÅÅ[2]Modi S, Jacot W, Yamashita T, et al. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. N Engl J Med. 2022;387(1):9-20. doi:10.1056/NEJMoa2203690
¡¶Ãâ·Ñ³ß´çÊ®´óÖ±²¥Æ½Ì¨,¸öÐÔ»¯Ñ§Ï°ÏµÍ³½á¹¹ÆÊÎö-ÇóÊÇ¡·ÊÓÆµËµÃ÷£ººØÓײØÖ¸×Å¹ãÆ½ÀäÀäµÄÎʵÀ¾ÝÒâ´óÀûýÌåLeggo±¨µÀÂÞÂíÏ£ÍûÒý½ø·ðÂÞÍÓÈø±ßºóÎÀ¿¨Ô¼µÂ²¢Ë¼Á¿½«ÄêÇáÖг¡²©Î¤ÄÉÈëµ½ÉúÒâÖÐСʱ¼äÒ»µ½·Å¼ÙµçÊÓÉÏ×ÜÄÜ¿´µ½ÇíÑþÒÌÂèдµÄµçÊÓ¾ç